NCT00424411已完成3 期
Efficacy and Safety of Inhaled Compared With Subcutaneous Human Insulin Therapy in Subjects With Type 2 Diabetes Mellitus: A Six-Month, Outpatient, Parallel Comparative Trial
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 300
- 试验地点
- 45
- 主要终点
- Primary outcome is 24 week change in baseline in HbA1c.
研究概览
简要总结
To determine, in subjects with Type 2 Diabetes Mellitus:
- Whether glycemic control can be achieved at least as effectively with an insulin regimen involving pre-meal EXUBERA™ (inhaled insulin) plus a single bedtime Ultralente injection as with a conventional subcutaneous insulin regimen involving 2 mixed Regular/NPH insulin injections per day.
- The toleration and safety of EXUBERA™ (inhaled insulin) therapy and its effects after 6 months, if any, on measures of pulmonary function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 Diabetes
- •Stable insulin regimen of at least 2 injections per day
排除标准
- •Any smoking within the last 6 months. Smoking is not permitted at any time during this study.
- •Subjects on insulin pump during 2 months prior to screening.
- •Subjects with poorly-controlled asthma, clinically significant chronic obstructive pulmonary disease, or other significant respiratory disease.
结局指标
主要结局
Primary outcome is 24 week change in baseline in HbA1c.
次要结局
- The secondary endpoints include the following efficacy assessments:
- Incidence of hypoglycemia
- Proportion of subjects with acceptable glycemic control (e.g., HbA1c<8%)
- Change from baseline in fasting lipid profile
- Change from baseline in fasting plasma glucose level
- Change from baseline in meal glucose response (2-hour postprandial increment in plasma glucose)
- Dose of insulin (total dose of injected sustained-duration insulin, and total dose of inhaled or injected Regular insulin during the study).
- Change from baseline in body weight
- Change from baseline in 24-hour home glucose profile (based on the area under the glucose profile curve calculated by the trapezoid rule with special weights assigned to the pre-breakfast and bedtime assessments).
- Patient satisfaction and preference.
研究者
研究点 (45)
Loading locations...
相似试验
已完成
3 期
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.Diabetes Mellitus, Type 1NCT00424437Pfizer320
已完成
3 期
Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 DiabetesDiabetes Mellitus, Type 1NCT00424333Pfizer320
已完成
3 期
Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.Diabetes Mellitus, Type 2NCT00370565Pfizer345
Unknown
不适用
Evaluation of the Efficiency of Two Different Teaching Methods in Safe Subcutaneous Injection SkillsComplication of InjectionNCT06389630Kocaeli Sağlık ve Teknoloji Üniversitesi82
已完成
4 期
Efficacy and safety of glycemic control in type 2 diabetes patients when switched to mitiglinide/voglibose fixed-dose combination therapy.type 2 diabetesJPRN-UMIN000007619Keio University School of Medicine Department of Nephrology, Endocrinology and Metabolism15